Study Explores Statin Discontinuation in Older Adults

A major new study suggests that many adults age 70 and older who have never experienced a heart attack or stroke may be able to stop taking statins without substantially increasing their short-term cardiovascular risks (ScienceDaily Health & Medicine). The study enrolled nearly 1,900 adults aged 70 and older who were taking statins specifically to prevent a first cardiovascular event. The initial findings were largely reassuring, with no statistically significant increase in heart attacks, strokes, or deaths after approximately two years compared to those who remained on the medications. [1]

However, the longer follow-up revealed a more concerning pattern. Over a period of up to four years, 12.7% of participants who stopped statins experienced a heart attack, stroke, or death, compared with 9.2% of those who kept taking the medications (ScienceDaily Health & Medicine). This higher rate of serious outcomes during the four-year follow-up represents a new finding in research on statin discontinuation among older adults. The study's lead author, Rita F. Redberg, noted that the difference may have emerged because this trial included more participants and tracked them for a longer period than earlier studies. [1]

The study involved 1,880 participants aged 70 and older (average age of 77; 53% men, and 47% women), all of whom had at least two chronic health conditions (ScienceDaily Health & Medicine). Researchers conducted the study between November 2021 and April 2026 across 24 medical centers in Switzerland, France, and the Netherlands. One limitation was that some participants did not remain in their originally assigned groups, which could have affected the findings. However, statistical analyses confirmed that the results remained unchanged despite these changes. [1]

A major new study suggests that many adults age 70 and older who have never experienced a heart attack or stroke may be able to stop taking statins without substantially increasing their short-term cardiovascular risks (ScienceDaily Health & Medicine). The study enrolled nearly 1,900 adults aged 70 and older who were taking statins specifically to prevent a first cardiovascular event. The initial findings were largely reassuring. After approximately two years, participants who stopped taking statins did not experience a statistically significant increase in heart attacks, strokes, or deaths compared with those who remained on the medications. [1]

However, the longer follow-up revealed a more concerning pattern. Over a period of up to four years, 12.7% of participants who stopped statins experienced a heart attack, stroke, or death, compared with 9.2% of those who kept taking the medications (ScienceDaily Health & Medicine). This increased risk of cardiovascular events during the extended follow-up period suggests that stopping statins may not be universally safe for all older adults, even those without a prior cardiovascular event. [1]

The study involved 1,880 participants aged 70 and older (average age of 77; 53% men, and 47% women), all of whom had at least two chronic health conditions (ScienceDaily Health & Medicine). Researchers conducted the study between November 2021 and April 2026 across 24 medical centers in Switzerland, France, and the Netherlands. The findings underscore the need for individualized decision-making between patients and healthcare professionals regarding the continuation or discontinuation of statins in this age group. [1]

A major new study suggests that many adults age 70 and older who have never experienced a heart attack or stroke may be able to stop taking statins without substantially increasing their short-term cardiovascular risks (ScienceDaily Health & Medicine). The study enrolled nearly 1,900 adults aged 70 and older who were taking statins specifically to prevent a first cardiovascular event. The initial findings were largely reassuring, as participants who stopped taking statins did not experience a statistically significant increase in heart attacks, strokes, or deaths compared with those who remained on the medications (ScienceDaily Health & Medicine). [1]

However, the longer follow-up revealed a more concerning pattern. Over a period of up to four years, 12.7% of participants who stopped statins experienced a heart attack, stroke, or death, compared with 9.2% of those who kept taking the medications (ScienceDaily Health & Medicine). This finding indicates that while the initial two-year period showed no significant increase in risk, the longer-term outcomes suggest a potential increase in cardiovascular events for those who discontinued their medication (ScienceDaily Health & Medicine). [1]

The study involved 1,880 participants aged 70 and older (average age of 77; 53% men, and 47% women), all of whom had at least two chronic health conditions (ScienceDaily Health & Medicine). Researchers conducted the study between November 2021 and April 2026 across 24 medical centers in Switzerland, France, and the Netherlands. The results suggest that discontinuing statins may be an option for many adults over 70 who have not previously experienced cardiovascular disease, especially when considering outcomes over the first two years (ScienceDaily Health & Medicine). [1]

Sources

ScienceDaily Health & Medicine

Prepared with AI assistance from the cited sources.